
Joaquin Duato
American corporate executive (b. 1962)
Joaquín Duato Boix (born April 1962) is a Spanish-American business executive. He is the chairman and chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate.2
From Wikipedia’s article on Joaquin Duato (this version), CC BY-SA 4.0.
Born Apr 1, 1962.1
About
He is the company's eighth CEO since it became a publicly-traded company in 1944. In 2023, Duato received $28.4 million, the highest paid CEO of any major US pharmaceutical company.
From Wikipedia’s article on Joaquin Duato, shared under CC BY-SA 4.0.2
Companies
- Johnson & JohnsonBoard member Jan 3, 2022 to now14
- Johnson & JohnsonChief executive officer Jan 3, 2022 to now14
- Hess CorporationBoard member Nov 7, 2019 to Mar 9, 202115
- Johnson & JohnsonVice chair Nov 9, 2018 to Feb 17, 202116
- Johnson & JohnsonChair May 5, 2016 to Jul 11, 201817
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Johnson & Johnson JNJ306,819 shares18$78.4M at $255.45Aug 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 13, 2026Sold 102,315 shares at $261.00 of Johnson & Johnson18
- Aug 13, 2026Sold 20,976 shares at $262.00 of Johnson & Johnson18
- Aug 13, 2026Exercised options 123,291 shares at $115.67 of Johnson & Johnson18
- Aug 5, 2026Sold 6,523 shares at $258.74 of Johnson & Johnson19
- Aug 5, 2026Sold 41,957 shares at $258.06 of Johnson & Johnson19
- Feb 15, 2026Shares withheld for tax 1,960 shares at $243.45 of Johnson & Johnson20
- Feb 15, 2026Exercised options 4,505 shares of Johnson & Johnson20
- Feb 15, 2026Shares withheld for tax 1,602 shares at $243.45 of Johnson & Johnson20
- Feb 15, 2026Exercised options 3,682 shares of Johnson & Johnson20
- Feb 13, 2026Shares withheld for tax 31,679 shares at $244.55 of Johnson & Johnson20
- Feb 13, 2026Exercised options 73,054 shares of Johnson & Johnson20
- Feb 13, 2026Shares withheld for tax 989 shares at $244.55 of Johnson & Johnson20
- Feb 13, 2026Exercised options 3,469 shares of Johnson & Johnson20
- Jan 26, 2026Sold 48,782 shares at $221.48 of Johnson & Johnson21
- Jan 26, 2026Sold 51,218 shares at $220.99 of Johnson & Johnson21
- Aug 22, 2025Sold 125,824 shares at $179.21 of Johnson & Johnson22
- Aug 22, 2025Exercised options 125,824 shares at $101.87 of Johnson & Johnson22
- Mar 18, 2025Gift 130,852 shares of Johnson & Johnson23
- Mar 18, 2025Gift 130,852 shares of Johnson & Johnson23
- Feb 18, 2025Shares withheld for tax 1,602 shares at $156.15 of Johnson & Johnson24
- Feb 15, 2025Exercised options 3,682 shares of Johnson & Johnson24
- Feb 14, 2025Shares withheld for tax 8,386 shares at $156.71 of Johnson & Johnson24
- Feb 14, 2025Exercised options 19,282 shares of Johnson & Johnson24
- Feb 14, 2025Shares withheld for tax 2,198 shares at $156.71 of Johnson & Johnson24
- Feb 14, 2025Exercised options 5,053 shares of Johnson & Johnson24
Early life and education
- Date not recordedESADE Business School3
- Date not recordedThunderbird School of Global Management3
- Date not recordedESADE3
Duato grew up in Valencia, Spain. His career in health care was influenced by his family. His mother was a nurse, his grandfather was a pediatrician, and his grandmother a pharmacist. Duato speaks English, Spanish, and Italian. He received a Master of Business Administration from ESADE Business School in Barcelona, Spain, and a Master of International Management from the Thunderbird School of Global Management in Phoenix, Arizona. Duato is a dual citizen of Spain and the US.
From Wikipedia’s article on Joaquin Duato (this version), CC BY-SA 4.0.
Career
Occupation: business executive.11
- Since 2023Chairperson, Johnson & Johnson8 10
- Since 2022Chief executive, Johnson & Johnson6
- Since 2022Board member, Johnson & Johnson7
- Since 2022Chief executive officer8 9
- Since 1989Worked at Johnson & Johnson4 5
In 1989, Duato began his career with Johnson & Johnson, joining Janssen Pharmaceuticals in Spain. After moving to the US in 2002, Duato was appointed executive vice president, worldwide chairman, pharmaceuticals in 2011. His growth strategy led to the turnaround of Johnson & Johnson’s struggling pharmaceutical business in the early 2000s.
In 2018 when he was promoted to vice chairman of Johnson & Johnson’s executive committee, he led the pharmaceuticals and consumer product divisions and oversaw supply-chain and technology operations. He also was interim Chief Information Officer.
Duato was appointed CEO in August 2021 which became effective in January 2022. He was also appointed to the company’s board of directors. In November 2022, he was elected chairman, effective January 2023. Duato oversaw the separation of Johnson & Johnson's consumer health segment, now an independent publicly traded company, Kenvue. During this time, Duato was the executive sponsor of the company's African Ancestry Leadership Council.
In 2023, Duato was the highest paid CEO of the major pharmaceutical companies, earning $28.4 million, a 117% increase over 2022.
From Wikipedia’s article on Joaquin Duato (this version), CC BY-SA 4.0.
Personal life
Duato is married, with two adult children, and lives in Pennsylvania.
He is the brother of actress Ana Duato, uncle of actor Miguel Bernardeau, and cousin of dancer Nacho Duato.
From Wikipedia’s article on Joaquin Duato (this version), CC BY-SA 4.0.
In the news
1 recent article from 1 outlet we read name Joaquin Duato. We match the full name, and check the article also names one of their companies or that they are well known.
- J&J's 6% slide on an imperfect quarter is a gift to prospective buyersCNBC, center, Oct 13, 2026…in inflammatory bowel and psoriatic diseases, and our belief that it can grow into a $10 billion franchise," CEO Joaquin Duato said on the earnings call.
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataJoaquin Duato on Wikidata
- 2WikipediaJoaquin Duato on Wikipedia
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14Wikidata and SEC EDGARJohnson & Johnson, Board member
- 15SEC EDGARHess Corporation, Board member
- 16SEC EDGARJohnson & Johnson, Vice chair
- 17SEC EDGARJohnson & Johnson, Chair
- 18
- 19SEC EDGARForm 4 filed Aug 7, 2026
- 20SEC EDGARForm 4 filed Feb 18, 2026
- 21SEC EDGARForm 4 filed Jan 28, 2026
- 22SEC EDGARForm 4 filed Aug 25, 2025
- 23SEC EDGARForm 4 filed Mar 19, 2025
- 24SEC EDGARForm 4 filed Feb 18, 2025
- 25Wikimedia CommonsJoaquin Duato photo by Stephanie Diani, CC BY-SA 4.0